Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05059626 · ClinicalTrials.gov registry record · Phase 4
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
A Phase 4 study of Endometriosis, sponsored by Penn State University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05059626 is a Phase 4 study of Endometriosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 28 participants, below the 264-participant average among 48 other Endometriosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05059626, a Phase 4 study of Endometriosis, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: To determine the effects of SERM and simvastatin interventions on endothelial dysfunction in women with endometriosis. Hypothesis: Treatment with the SERM (bazedoxifene + conjugated estrogen) or with simvastatin will decrease systemic inflammation and improve specific measures of cardiovascular function including endothelium-dependent vasodilation.
Conditions Studied
Interventions
- DRUG simvastatin 10mg
- DRUG Bazedoxifene 20/Estrogens,Con 0.45Mg Tb
Study Locations (1)
Connecticut
- The John B. Pierce Laboratory - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05059626
The ClinicalTrials.gov registry entry for NCT05059626 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 48 other Endometriosis trials with a reported enrollment target (89% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which simvastatin 10mg is the first listed.
NCT05059626 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05059626 about?
NCT05059626 is a clinical study titled "Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee". Purpose: To determine the effects of SERM and simvastatin interventions on endothelial dysfunction in women with endometriosis. Hypothesis: Treatment with the SERM (bazedoxifene + conjugated estrogen) or with simvastatin will decrease systemic inflammation and improve specific measures of cardiovas...
What is the current status of trial NCT05059626?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2023-12-01. Estimated completion is 2026-12-31.
What conditions does trial NCT05059626 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT05059626?
The interventions under investigation include: simvastatin 10mg (DRUG), Bazedoxifene 20/Estrogens,Con 0.45Mg Tb (DRUG).
Who is sponsoring clinical trial NCT05059626?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05059626 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Supplementation in Adolescent Girls With Endometriosis
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.